Dexmedetomidine After Cesarean for the Treatment of Nausea and Shivering

• Status: Completed
• Trial end date: 2020-12-31
• Target enrollment: 0
• Participant gender: Female

Summary

This is a randomized double blinded trial to determine if a small dose of dexmedetomidine can prevent and relieve nausea and shivering, two of the more common complaints after cesarean delivery.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Beth Israel Deaconess Medical Center
• Treatments: Dexmedetomidine

Criteria

Inclusion Criteria:

• Elective cesarean delivery

• ≥ 18 years of age

• Singleton pregnancy

• Term delivery (37 weeks or greater gestation)

• Spinal or combined spinal-epidural anesthesia is planned

Exclusion Criteria:

• Non-elective cesarean delivery

• Receiving misoprostil or carboprost

• Postpartum hemorrhage greater that 1000cc

• Chronic opioid use

• History of chronic nausea or itching in pregnancy

• Receiving medications for nausea

• Inability to provide written informed consent

• Receiving of any of the following medications intraoperatively: misoprostil, carboprost, medications for nausea

• Postpartum hemorrhage greater that 1000cc